These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Valpromide is a poor inhibitor of the cytosolic epoxide hydrolase.
    Author: Pacifici GM, Temellini A, Giuliani L, Rane A, Thomas H, Oesch F.
    Journal: Arch Toxicol; 1989; 63(2):157-9. PubMed ID: 2499297.
    Abstract:
    The effect of the antiepileptics valpromide and sodium valproate on the cytosolic epoxide hydrolase was studied in human fetal liver, kidneys and adrenals and from human adult liver and kidneys. Trans-stilbene oxide was used as substrate. Valpromide (10 mM) lowered the activity of the epoxide hydrolase to one half of the control in all organs studied. Sodium valproate (10 mM) was less powerful as an inhibitor than valpromide; however, it exerted a significant inhibition in all tissues studied.
    [Abstract] [Full Text] [Related] [New Search]